Darwin & Wallace reports rebound in sales
The nine-strong, Imbiba-backed group reported a recovery in sales for FY22, and revealed it considered a listing post-pandemic
Already have an account? Sign in
The nine-strong, Imbiba-backed group reported a recovery in sales for FY22, and revealed it considered a listing post-pandemic
Already have an account? Sign in